Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donor Tregs for Steroid-Refractory Chronic GVHD
NCT02385019Phase 2Unknown
- Sponsor
- Instituto de Medicina Molecular João Lobo Antunes
- Start
- Mar 2015
- Primary completion
- Mar 2019
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
A Phase 2 trial of donor regulatory T lymphocytes in chronic graft-versus-host disease (cGVHD), sponsored by Instituto de Medicina Molecular João Lobo Antunes. Status: unknown.
02
Drugs
donor regulatory T lymphocytes
03
Conditions
chronic graft-versus-host disease (cGVHD)
Beyond the preview
Go deeper on NCT02385019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02385019.